We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,159
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.22%
2 Technology 4.92%
3 Industrials 4.28%
4 Consumer Discretionary 4.13%
5 Healthcare 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NXTP
8326
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$39K ﹤0.01%
+827
New +$48.4K
GPL
8327
DELISTED
Great Panther Mining Limited
GPL
$39K ﹤0.01%
3,364
+1,130
+51% +$13.8K
SAUC
8328
DELISTED
Diversified Restaurant Holdings, Inc. Common stock
SAUC
$39K ﹤0.01%
+31,278
New +$39.2K
ATXS
8329
DELISTED
Astria Therapeutics
ATXS
$38K ﹤0.01%
+664
New +$61.2K
MDVL
8330
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$38K ﹤0.01%
+43
New +$36.5K
STAB
8331
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$38K ﹤0.01%
15,389
+1,888
+14% +$5.25K
FGP
8332
CALL
DELISTED
Ferrellgas Partners, L.P.
FGP
$38K ﹤0.01%
+11,300
New +$39.7K
AAV
8333
CALL
DELISTED
Advantage Oil & Gas Ltd
AAV
$38K ﹤0.01%
+12,100
New +$37.5K
CYTR
8334
CALL
DELISTED
CytRx Corp
CYTR
$38K ﹤0.01%
33,400
+8,200
+33% +$12.3K
PDLI
8335
PUT
DELISTED
PDL BioPharma, Inc.
PDLI
$38K ﹤0.01%
16,400
-600
-4% -$1.68K
DRRX
8336
PUT
DELISTED
DURECT Corp
DRRX
$37K ﹤0.01%
+2,340
New +$48K
IHT
8337
InnSuites Hospitality Trust
IHT
$15.4M
$37K ﹤0.01%
26,000
+13,042
+101% +$22.8K
VIRX
8338
PUT
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$37K ﹤0.01%
+494
New +$44K
SPRT
8339
DELISTED
support.com, Inc.
SPRT
$37K ﹤0.01%
+13,123
New +$37K
RRTS
8340
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$37K ﹤0.01%
702
-1,862
-73% -$104K
TOO
8341
CALL
DELISTED
Teekay Offshore Partners L.P.
TOO
$37K ﹤0.01%
+14,100
New +$37.4K
EFOI icon
8342
Energy Focus
EFOI
$19.1M
$36K ﹤0.01%
547
-169
-24% -$13.8K
NNDM
8343
Nano Dimension
NNDM
$348M
$36K ﹤0.01%
+1,730
New +$29.1K
NVAX icon
8344
CALL
Novavax
NVAX
$1.33B
$36K ﹤0.01%
1,350
-3,330
-71% -$113K
TAOP icon
8345
Taoping
TAOP
$8.58M
$36K ﹤0.01%
15
+1
+7% +$3.03K
URG
8346
Ur-Energy
URG
$541M
$36K ﹤0.01%
53,369
-161,282
-75% -$115K
WWR icon
8347
Westwater Resources
WWR
$77.8M
$36K ﹤0.01%
1,786
+702
+65% +$16.9K
VIRX
8348
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$36K ﹤0.01%
+485
New +$43.2K
ADXS
8349
DELISTED
Advaxis Inc
ADXS
$36K ﹤0.01%
1,658
-186
-10% -$4.82K
ADXS
8350
PUT
DELISTED
Advaxis Inc
ADXS
$36K ﹤0.01%
1,667
-193
-10% -$5K

Similar funds

Ken Griffin's Q2 2018 Portfolio in Review

As of Q2 2018, Ken Griffin held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Ken Griffin deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,159 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 5% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Ken Griffin's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Ken Griffin added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Ken Griffin's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Ken Griffin fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Ken Griffin's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Ken Griffin opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.